Answers are grounded in this paper and cite their sources.
Purpose: Aerodynamic voice measures differentiate between normophonic and dysphonic voices; however, their diagnostic utility and sensitivity to change remain indeterminate. This study examined whether aerodynamic voice measures delineate between laryngeal pathologies and/or track change in vocal function following voice therapy. Method: Using a retrospective observational cohort design with data from the University of Wisconsin–Madison Voice and Swallow Clinics Outcomes Database, aerodynamic voice measures (phonation threshold pressure [PTP], subglottal pressure, laryngeal airway resistance [LAR], and glottal airflow) from initial voice evaluations of 1,281 adults—across 12 years—were compared across patients presenting with benign vocal fold (VF) lesions, primary muscle tension dysphonia (pMTD), VF paralysis, laryngeal dystonia and/or vocal tremor, presbyphonia, and VF scar. We further examined whether there were changes in aerodynamic measures, in a subset of these patients ( n = 87), in response to voice therapy. Results: Patients with pMTD had reduced PTP ( p < .001) and/or subglottal pressure ( p < .001) compared to patients with benign VF lesions and VF scar. VF paralysis had lower LAR ( p < .001) and high glottal airflow ( p < .001) compared to patients with other diagnoses and reduced subglottal pressure ( p < .001) compared to benign VF lesions. Magnitude of improvement in PTP and subglottal pressure was greater with longer therapy durations across all diagnoses ( p < .001). Conclusions: Aerodynamic measures differentiated several laryngeal pathologies at the time of initial assessment, with the most prominent differences observed in patients with VF paralysis. Following voice therapy, PTP was sensitive to changes in laryngeal function, with greater improvements observed after longer therapy durations. These findings suggest that aerodynamic measures may help characterize diagnosis-specific differences and quantify therapy-associated changes, while indicating that posttreatment outcomes should be interpreted in the context of therapy duration.
No takes yet. Share an insight, caveat, or question.
Venkatraman et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: